Key facts
- Crop Diagnostix’s last known valuation is $10.5M (Dec 2024).
- It has raised $3.6M across 1 recorded rounds; the latest was Seed Round ($3.5M) in Nov 2024.
- Notable investors include Flybridge (New York), Harvard Innovation Launch Lab, Tau Ventures, The MBA Fund, Contour Venture Partners — 13 tracked in total.
- Crop Diagnostix has filed 1 Form D with the SEC, most recently Dec 2024 ($3.5M sold to 24 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Crop Diagnostix
Funding rounds
1 roundsAbout Crop Diagnostix
Developer of an innovative agricultural diagnostic platform designed for optimizing crop health and yield. The company's platform uses genomics and AI to build the future of predictive agriculture to diagnose plant health by analyzing gene expression to grow more food sustainably, enabling farmers to optimize inputs and maximize yield through precise and sustainable farming practices.
- Sector
- Materials and Resources
- HQ
- San Diego, CA, United States
- Founded
- 2023
- Employees
- 10
- Website
- cropdiagnostix.com/
- Ownership
- Privately Held (backing)
Crop Diagnostix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Crop Diagnostix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Crop Diagnostix in its N-PORT filings yet. We sweep new filings monthly.